Document Type


Original Publication Date


Date of Submission

April 2021


Aims: Platelet rich plasma (PRP) has been used in tissue repair to treat numerous inflammatory pathophysiologies. Recent studies have elucidated that the bioactive lipid fraction of PRP significantly contributes towards the resolution of inflammation. There has been great interest in how therapeutics could modulate the PRP lipidome to formulate a more pro-resolving matrix. Many of the pathways used to produce either pro-resolving or pro-inflammatory lipids are shared between ω-3 and ω-6 polyunsaturated fatty acids (PUFA). Here, we explored the separate and interacting effects acute exogenous ω-3 PUFA supplementation and aspirin had on the lipidome of PRP within 6 hours.

Methods:PRP from 45 patients was obtained at baseline and after 6-hours from either control or those receiving one 1400 mg fish oil tablet, Bayer low-dose aspirin (81mg), or combinational therapy. Lipids were acquired by liquid chromatography mass spectrometry. Spearman rank correlation analysis visually assessed what effects treatments had on the relative abundance of PUFA derivatives. The control group was referenced for lipid selection across groups; lipids were selected on the basis that they significantly (p

Results: Fish oil ω-3 PUFA supplementation and aspirin had separate and interacting effects on oxylipin and neutral lipid correlations. Strongly correlated (rho > 0.65) ω-6 PUFA metabolites were reversed or reduced in magnitude following either treatment. A total of 24 lipid species were significantly modulated in the fish oil treatment group, with notable (p4), and lipoxin A4 (LXA4).

Conclusion: We can confirm that fish oil supplementation and aspirin do exert modulatory effects on the lipid fraction of PRP within a short period of time (6-hours). The PUFAs composing fish oil impacted a wide range of the lipidome – possibly though a mechanism of ω-3/ω-6 enzymatic competition. Our results support that ω-3 PUFA supplementation may improve the efficacy of PRP for short-term use.

Is Part Of

VCU Pharmacotherapy and Outcomes Science Publications